Augmentation of kidney injury by basic fibroblast growth factor or platelet-derived growth factor does not induce progressive diabetic nephropathy in the Goto Kakizaki model of non-insulin-dependent diabetes

Journal of Laboratory and Clinical Medicine

Volumn 134, Issue 3, 1999, Pages 304-312

  Riley, Stephen G ^a   Steadman, Robert ^a   Williams, John D ^a   Floege, Jürgen ^a   Phillips, Aled O ^a  

^a Cardiff Royal Infirmary   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 0033198789     PISSN: 00222143     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0022-2143(99)90211-1     Document Type: Article

References (41)

1. 1. Joint Working Party on Diabetic Renal Failure of the British Diabetic Association, the Renal Association, and the Research Unit of the Royal College of Physicians. Renal failure in diabetics in the UK: deficient provision of care in 1985. Diabet Med 1988;5:79-84.
2. 2. United States Renal Data System 1990 Annual Data Report. Causes of ESRD. Am J Kidney Dis 1990;15(suppl 2):22-7.
3. 3. Ritz E, Stefanski A. Diabetic nephropathy in type II diabetes. Am J Kidney Dis 1996;27:167-94.
4. 4. Phillips AO, Baboolal K, Gröne HJ, et al. Sequential metabolic and renal changes in a non-obese, normotensive rat model of type II diabetes. J Am Soc Nephrol 1998;9:639.
5. 5. Goto Y, Kakizaki M, Masaki N. Production of spontaneous diabetic rats by repetition of selective breeding. Tohoku J Exp Med 1976;119:85-90.
6. 6. Phillips AO, Steadman R, Topley N, Williams JD. Elevated D-glucose concentrations modulate TGF-β1 synthesis by human cultured renal proximal tubular cells: the permissive role of platelet derived growth factor. Am J Pathol 1995;147:362-74.
7. 7. Phillips AO, Topley N, Steadman R, Morrisey K, Williams J. Induction of TGF-β1 synthesis in D-glucose primed human proximal tubular cells: differential stimulation by the macrophage derived pro-inflammatory cytokines IL-1β and TNFα. Kidney Int 1996;50:1546-54.
8. 8. Phillips AO, Morrisey R, Steadman R, Williams JD. Polarity of stimulation and secretion of TGF-β1 by proximal tubular cells. Am J Pathol 1997;150:1101-11.
9. 9. Floege J, Eng E, Young BA, et al. Infusion of platelet-derived growth factor or basic fibroblast growth factor induces selective glomerular mesangial cell proliferation and matrix accumulation in rats. J Clin Invest 1993;92:2952-62.
10. 10. Tang WW, Ulich TR, Lacey DL, et al. Platelet derived growth factor BB induces renal tubulointerstitial myofibroblast formation and tubulointerstitial fibrosis. Am J Pathol 1996; 148:1169-80.
11. 11. Floege J, Kriz W, Schulze M, et al. Basic fibroblast growth factor augments podocyte injury and induces glomerulosclerosis in rats with experimental membranous nephropathy. J Clin Invest 1995;96:2809-19.
12. 12. Floege J, Alpers CE, Sage EH, et al. Markers of complement-dependent and complement-independent glomerular visceral epithelial cell injury in vivo. Lab Invest 1992;67:486-97.
13. 13. Johnson RJ, Garcia RL, Pritzl P, Alpers CE. Platelets mediate glomerular cell proliferation in immune complex nephritis induced by anti-mesangial cell antibodies in the rat. Am J Pathol 1990;136:369-74.
14. 14. Skalli O, Ropraz P, Trzeciak A, Benzonana G, Gillessen D, Gabbiani G. A monoclonal antibody against alpha-smooth muscle actin: a new probe for smooth muscle differentiation. Am J Pathol 1986;118:85-95.
15. 15. Altmannsberger M, Weber K, Droste R, Osborn M. Desmin is a specific marker for rhabdomyosarcomas of human and rat origin. Am J Pathol 1985;118:85-95.
16. 16. Dijkstra CD, Dopp EA, Joling P, Kraal G. The heterogeneity of mononuclear phagocytes in lymphoid organs: distinct macrophage subpopulations in the rat recognised by monoclonal antibodies ED1, ED2 and ED3. Immunology 1985;54:589-99.
17. 17. Hugo C, Hugo C, Pichler R, et al. The cytoskeletal linking proteins, moesin and radixin, are upregulated by platelet derived growth factor, but not basic fibroblast growth factor in experimental mesangial proliferative glomerulonephritis. J Clin Invest 1996;97:2499-508.
18. 18. Kliem V, Johnson RJ, Alpers CE, et al. Mechanisms involved in the pathogenesis of tubulointerstitial fibrosis in 5/6-nephrectomized rats. Kidney Int 1996;49:666-78.
19. 19. Johnson RJ, Iida H, Alpers CE, et al. Expression of smooth muscle cell phenotype by rat mesangial cells in immune complex nephritis. J Clin Invest 1991;87:847-58.
20. 20. Floege J, Johnson RJ, Gordon K, et al. Increased synthesis of extracellular matrix in mesangial proliferative nephritis. Kidney Int 1991;40:477-88.
21. 21. The Diabetes Control and Complications Trial Research Group. The effect of intensive treatment of diabetes on the development and progression of long term complications in insulin dependant diabetes mellitus. N Engl J Med 1993;329:977-86.
22. 22. The Diabetes Control and Complications Research Group. Effect of intensive therapy on the development and progression of diabetic nephropathy in the Diabetes Control and Complications Trial. Kidney Int 1995;47:1703-20.
23. 23. Pagtalunan ME, Millar PL, Eagle SJ, et al. Podocyte loss and progressive glomerular injury in type 2 diabetes. J Clin Invest 1997;99:342-8.
24. 24. Brito PL, Fioretto P, Drummond K, et al. Proximal tubular basement membrane width in insulin-dependent diabetes mellitus. Kidney Int 1998;53:754-61.
25. 25. Ihm CG, Lee GSL, Nast CC, et al. Early increased renal pro-collagen α1 (IV) mRNA levels in streptozotocin induced diabetes. Kidney Int 1992;41:768-77.
26. 26. Young BA, Johnson RJ, Alpers CE, et al. Cellular events in the evolution of experimental diabetic nephropathy. Kidney Int 1995;47:935-44.
27. 27. Eng E, Floege J, Young BA, Couser WG, Johnson RJ. Does extracellular matrix expansion in glomerular disease require mesangial cell proliferation? Kidney Int 1994;45:S45-7.
28. 28. Mauer SM, Steffes MW, Ellis EE, Sutherland DER, Brown DM, Goetz FC. Structural-functional relationships in diabetic nephropathy. J Clin Invest 1984;74:1143-55.
29. 29. Floege J, Eng E, Young BA, Johnson RJ. Factors involved in the regulation of mesangial cell proliferation in vitro and in vivo. Kidney Int 1993;43(suppl 39):S47-54.
30. 30. Silver B, Jaffer FE, Abboud HE. Platelet derived growth factor synthesis in mesangial cells: induction by multiple peptide mitoyens. Proc Natl Acad Sci 1989;86:1056-60.
31. 31. Doi T, Vlassara H, Kirstein M, Yamada Y, Striker GE, Striker LJ. Receptor specific increases in extracellular matrix production in mouse mesangial cells by advanced glycosylation end products is mediated via platelet derived growth factor. Proc Natl Acad Sci 1992;89:2873-7.
32. 32. Johnson RJ, Raines EW, Floege J, et al. Inhibition of mesangial cell proliferation and matrix expansion in glomerulonephritis in the rat by antibody to platelet-derived growth factor. J Exp Med 1992;175:1413-6.
33. 33. Mizutani M, Okuda Y, Yamaoka T, et al. High glucose and hyperosmolarity increase platelet-derived growth factor mRNA levels in cultured human vascular endothelial cells. Biochem Biophys Res Commun 1992;187:664-9.
34. 34. Guillausseau PJ, Dupuy E, Bryckaert MC, et al. Platelet-derived growth factor in type 1 diabetes mellitus. Eur J Clin Invest 1989;19:172-5.
35. 35. Kriz W, Elger M, Nagata M, et al. The role of the podocyte in the development of glomerular sclerosis. Kidney Int 1994; 45:S64-72.
36. 36. Rifkin DB, Moscatelli D. Recent developments in the cell biology of basic fibroblast growth factor. J Cell Biol 1989;109:1-6.
37. 37. Burgess WH, Maciag T. The heparin-binding (fibroblast) growth factor family of proteins. Annu Rev Biochem 1989;58:575-606.
38. 38. Zhang G, Ichimura T, Wallin A, Kan M, Stevens JL. Regulation of rat proximal tubule epithelial cell growth by fibroblast growth factors, insulin like growth factor-1 and transforming growth factor beta, and analysis of fibroblast growth factors in rat kidney. J Cell Physiol 1991;148:295-305.
39. 39. Floege J, Eng E, Lindner V, et al. Rat glomerular mesangial cells synthesize basic fibroblast growth factor. J Clin Invest 1992;90:2362-9.
40. 40. Kanda S, Hisamatsu H, Igawa T, et al. Peritubular endothelial cell proliferation in mice during compensatory renal growth after unilateral nephrectomy. Am J Physiol 1993; 265:F712-6.
41. 41. Stephan CC, Chang KC, LeJeune W, et al. Role for heparin-binding growth factors in glucose-induced vascular dysfunction. Diabetes 1988;47:1771-8.